Factors influencing outcome of angiographic embolization for gastroduodenal hemorrhage related to peptic ulceration.


Journal

European journal of radiology
ISSN: 1872-7727
Titre abrégé: Eur J Radiol
Pays: Ireland
ID NLM: 8106411

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 20 04 2023
revised: 19 06 2023
accepted: 10 07 2023
medline: 22 8 2023
pubmed: 19 7 2023
entrez: 18 7 2023
Statut: ppublish

Résumé

Long-term outcome and prognostic factors of transcatheter embolization for gastroduodenal peptic ulcer bleeding are unknown. This study was conducted to evaluate the clinical outcome and factors associated with early recurrent bleeding and 30-day mortality of transcatheter arterial embolization (TAE) for severe, upper gastroduodenal hemorrhage associated with peptic ulcer and refractory to medical and endoscopic therapy. A monocenter, retrospective study from 2005 to 2020 including 76 consecutive patients who underwent TAE as first-line therapy for bleeding gastroduodenal peptic ulcers refractory to endoscopic therapy. Patient demographics, endoscopy findings, co-morbidities and interventional procedure findings were recorded. The outcome measures were technical and clinical success, procedure related complications, recurrent bleeding, length of hospital stay, 30-day mortality and overall survival. The technical success rate was 96% and the clinical success rate was 65,8%. The rebleeding and 30-day mortality rate were 30,7% and 22,4% respectively. A higher international normalized ratio (INR) was a statistically significant risk factor for 30-day mortality (OR, 7.15; 95% CI, 1.67-30.70; p = 0.008). The mean overall survival was 3.76 years (1.16---5.09; 95% CI); a lower Charlson Comorbidity Index (CCI) and a lower Rockall score were significantly associated with a longer overall survival (HR, 1.24; 95% CI, 1.14-1.35; p = 0.0001; HR, 1.32; 95% CI, 1.10-1.59; p = 0.003) respectively. Early rebleeding was significantly associated with a lower overall survival (HR, 2.72; 95% CI, 1.57-4.71; p = 0.0004). A higher INR was a significant risk factor with a higher 30-day mortality. A lower CCI, a lower Rockall score and the absence of early rebleeding were significantly associated with a longer overall survival.

Identifiants

pubmed: 37463549
pii: S0720-048X(23)00284-X
doi: 10.1016/j.ejrad.2023.110970
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110970

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Charlotte Vanhoenacker (C)

Department of Radiology, University Hospitals KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: charlottevanhoenacker@live.be.

Eva Hufkens (E)

Department of Gastroenterology and Hepatology, University Hospitals KU Leuven,Herestraat 49, 3000 Leuven, Belgium. Electronic address: evahufkens@hotmail.com.

Annouschka Laenen (A)

Department of Public Health and Primary Care, Leuven Biostatistics and Statistical Bioinformatics Centre, Kapucijnenvoer 35, 3000 Leuven, Belgium. Electronic address: annouschka.laenen@kuleuven.be.

Lawrence Bonne (L)

Department of Radiology, University Hospitals KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: lawrence.bonne@uzleuven.be.

Eveline Claus (E)

Department of Radiology, University Hospitals KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: eveline.claus@uzleuven.be.

Jo Peluso (J)

Department of Radiology, University Hospitals KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: jo.peluso@uzleuven.be.

Ingrid Demedts (I)

Department of Gastroenterology and Hepatology, University Hospitals KU Leuven,Herestraat 49, 3000 Leuven, Belgium. Electronic address: ingrid.demedts@uzleuven.be.

Wim Laleman (W)

Department of Gastroenterology and Hepatology, University Hospitals KU Leuven,Herestraat 49, 3000 Leuven, Belgium. Electronic address: wim.laleman@uzleuven.be.

Alexander Wilmer (A)

Department of General Internal Medicine, University Hospitals KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: alexander.wilmer@uzleuven.be.

Geert Maleux (G)

Department of Radiology, University Hospitals KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: geert.maleux@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH